These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 16087719)
1. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats. Sancho V; Trigo MV; González N; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML J Mol Endocrinol; 2005 Aug; 35(1):27-38. PubMed ID: 16087719 [TBL] [Abstract][Full Text] [Related]
2. The action of GLP-1 and exendins upon glucose transport in normal human adipocytes, and on kinase activity as compared to morbidly obese patients. Sancho V; Nuche B; Arnés L; Cancelas J; González N; Díaz-Miguel M; Martín-Duce A; Valverde I; Villanueva-Peñacarrillo ML Int J Mol Med; 2007 Jun; 19(6):961-6. PubMed ID: 17487430 [TBL] [Abstract][Full Text] [Related]
3. Effect of GLP-1 on glucose transport and its cell signalling in human myocytes. González N; Acitores A; Sancho V; Valverde I; Villanueva-Peñacarrillo ML Regul Pept; 2005 Mar; 126(3):203-11. PubMed ID: 15664668 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle. Arnés L; González N; Tornero-Esteban P; Sancho V; Acitores A; Valverde I; Delgado E; Villanueva-Peñacarrillo ML Int J Mol Med; 2008 Jul; 22(1):127-32. PubMed ID: 18575785 [TBL] [Abstract][Full Text] [Related]
5. Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle. Acitores A; González N; Sancho V; Valverde I; Villanueva-Peñacarrillo ML J Endocrinol; 2004 Mar; 180(3):389-98. PubMed ID: 15012593 [TBL] [Abstract][Full Text] [Related]
6. Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states. Moreno P; Nuche-Berenguer B; Gutiérrez-Rojas I; Acitores A; Sancho V; Valverde I; González N; Villanueva-Peñacarrillo ML J Mol Endocrinol; 2012 Feb; 48(1):37-47. PubMed ID: 22065862 [TBL] [Abstract][Full Text] [Related]
7. Participation of protein kinases in the stimulant action of GLP-1 on 2-deoxy-D-glucose uptake by normal rat skeletal muscle. Acitores A; González N; Sancho V; Arnés L; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML Horm Metab Res; 2005 May; 37(5):275-80. PubMed ID: 15971149 [TBL] [Abstract][Full Text] [Related]
8. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats. Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463 [TBL] [Abstract][Full Text] [Related]
9. Effect of GLP-1 on D-glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects. Sancho V; Trigo MV; Martín-Duce A; Gonz Lez N; Acitores A; Arnés L; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML Int J Mol Med; 2006 Jun; 17(6):1133-7. PubMed ID: 16685426 [TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477 [TBL] [Abstract][Full Text] [Related]
11. Effect of GLP-1 on lipid metabolism in human adipocytes. Villanueva-Peñacarrillo ML; Márquez L; González N; Díaz-Miguel M; Valverde I Horm Metab Res; 2001 Feb; 33(2):73-7. PubMed ID: 11294496 [TBL] [Abstract][Full Text] [Related]
12. Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1. Idris I; Patiag D; Gray S; Donnelly R Biochem Pharmacol; 2002 Mar; 63(5):993-6. PubMed ID: 11911852 [TBL] [Abstract][Full Text] [Related]
13. GLP-1 signalling and effects on glucose metabolism in myocytes from type 2 diabetic patients. González N; Sancho V; Martín-Duce A; Tornero-Esteban P; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML Int J Mol Med; 2005 Oct; 16(4):747-52. PubMed ID: 16142415 [TBL] [Abstract][Full Text] [Related]
14. Characteristic of GLP-1 effects on glucose metabolism in human skeletal muscle from obese patients. Villanueva-Peñacarrillo ML; Martín-Duce A; Ramos-Álvarez I; Gutiérrez-Rojas I; Moreno P; Nuche-Berenguer B; Acitores A; Sancho V; Valverde I; González N Regul Pept; 2011 Jun; 168(1-3):39-44. PubMed ID: 21419173 [TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes. Luque MA; González N; Márquez L; Acitores A; Redondo A; Morales M; Valverde I; Villanueva-Peñacarrillo ML J Endocrinol; 2002 Jun; 173(3):465-73. PubMed ID: 12065236 [TBL] [Abstract][Full Text] [Related]
16. Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models. Villanueva-Peñacarrillo ML; Puente J; Redondo A; Clemente F; Valverde I Endocrine; 2001 Jul; 15(2):241-8. PubMed ID: 11720253 [TBL] [Abstract][Full Text] [Related]
17. Effects of glucagon-like peptide 1 on the kinetics of glycogen synthase a in hepatocytes from normal and diabetic rats. López-Delgado MI; Morales M; Villanueva-Peñacarrillo ML; Malaisse WJ; Valverde I Endocrinology; 1998 Jun; 139(6):2811-7. PubMed ID: 9607788 [TBL] [Abstract][Full Text] [Related]
18. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Tourrel C; Bailbe D; Lacorne M; Meile MJ; Kergoat M; Portha B Diabetes; 2002 May; 51(5):1443-52. PubMed ID: 11978641 [TBL] [Abstract][Full Text] [Related]
19. GLP-1 (7-36) amide: effects on glucose transport and metabolism in rat adipose tissue. Perea A; Viñambres C; Clemente F; Villanueva-Peñacarrillo ML; Valverde I Horm Metab Res; 1997 Sep; 29(9):417-21. PubMed ID: 9370107 [TBL] [Abstract][Full Text] [Related]
20. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats. Ozyazgan S; Kutluata N; Afşar S; Ozdaş SB; Akkan AG Pharmacology; 2005 Jun; 74(3):119-26. PubMed ID: 15746570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]